These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling. Qosa H, Abuasal BS, Romero IA, Weksler B, Couraud PO, Keller JN, Kaddoumi A. Neuropharmacology; 2014 Apr; 79():668-78. PubMed ID: 24467845 [Abstract] [Full Text] [Related]
4. P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta. Tai LM, Loughlin AJ, Male DK, Romero IA. J Cereb Blood Flow Metab; 2009 Jun; 29(6):1079-83. PubMed ID: 19367293 [Abstract] [Full Text] [Related]
5. Anti-Aβ-MAb and dually decorated nanoliposomes: effect of Aβ1-42 peptides on interaction with hCMEC/D3 cells. Markoutsa E, Papadia K, Clemente C, Flores O, Antimisiaris SG. Eur J Pharm Biopharm; 2012 May; 81(1):49-56. PubMed ID: 22386910 [Abstract] [Full Text] [Related]
6. High-Density Lipoprotein Mimetic Peptide 4F Efficiently Crosses the Blood-Brain Barrier and Modulates Amyloid-β Distribution between Brain and Plasma. Swaminathan SK, Zhou AL, Ahlschwede KM, Curran GL, Lowe VJ, Li L, Kandimalla KK. J Pharmacol Exp Ther; 2020 Nov; 375(2):308-316. PubMed ID: 32778535 [Abstract] [Full Text] [Related]
7. Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier. Kuntz M, Candela P, Saint-Pol J, Lamartinière Y, Boucau MC, Sevin E, Fenart L, Gosselet F. J Alzheimers Dis; 2015 Nov; 48(3):849-62. PubMed ID: 26402114 [Abstract] [Full Text] [Related]
8. Modulation of Amyloid-β1-40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier. Merino-Zamorano C, Fernández-de Retana S, Montañola A, Batlle A, Saint-Pol J, Mysiorek C, Gosselet F, Montaner J, Hernández-Guillamon M. J Alzheimers Dis; 2016 May 25; 53(2):677-91. PubMed ID: 27232214 [Abstract] [Full Text] [Related]
9. Parametric investigation of static and dynamic cell culture conditions and their impact on hCMEC/D3 barrier properties. Hinkel S, Mattern K, Dietzel A, Reichl S, Müller-Goymann CC. Int J Pharm; 2019 Jul 20; 566():434-444. PubMed ID: 31163193 [Abstract] [Full Text] [Related]
10. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding. Shackleton B, Crawford F, Bachmeier C. Fluids Barriers CNS; 2016 Aug 08; 13(1):14. PubMed ID: 27503326 [Abstract] [Full Text] [Related]
11. Regulation of Tight-Junction Integrity by Insulin in an In Vitro Model of Human Blood-Brain Barrier. Ito S, Yanai M, Yamaguchi S, Couraud PO, Ohtsuki S. J Pharm Sci; 2017 Sep 08; 106(9):2599-2605. PubMed ID: 28456720 [Abstract] [Full Text] [Related]
12. Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain. Swaminathan SK, Ahlschwede KM, Sarma V, Curran GL, Omtri RS, Decklever T, Lowe VJ, Poduslo JF, Kandimalla KK. J Cereb Blood Flow Metab; 2018 May 08; 38(5):904-918. PubMed ID: 28569090 [Abstract] [Full Text] [Related]
13. Changes of blood-brain-barrier function and transfer of amyloid beta in rats with collagen-induced arthritis. Lai PH, Wang TH, Zhang NY, Wu KC, Yao CJ, Lin CJ. J Neuroinflammation; 2021 Jan 30; 18(1):35. PubMed ID: 33516259 [Abstract] [Full Text] [Related]
14. Transthyretin participates in beta-amyloid transport from the brain to the liver--involvement of the low-density lipoprotein receptor-related protein 1? Alemi M, Gaiteiro C, Ribeiro CA, Santos LM, Gomes JR, Oliveira SM, Couraud PO, Weksler B, Romero I, Saraiva MJ, Cardoso I. Sci Rep; 2016 Feb 03; 6():20164. PubMed ID: 26837706 [Abstract] [Full Text] [Related]
15. Semimechanistic Population Pharmacokinetic Modeling to Investigate Amyloid Beta Trafficking and Accumulation at the BBB Endothelium. Wang Z, Sharda N, Curran GL, Li L, Lowe VJ, Kandimalla KK. Mol Pharm; 2021 Nov 01; 18(11):4148-4161. PubMed ID: 34664956 [Abstract] [Full Text] [Related]
16. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier. Do TM, Noel-Hudson MS, Ribes S, Besengez C, Smirnova M, Cisternino S, Buyse M, Calon F, Chimini G, Chacun H, Scherrmann JM, Farinotti R, Bourasset F. J Alzheimers Dis; 2012 Nov 01; 30(1):155-66. PubMed ID: 22391220 [Abstract] [Full Text] [Related]
17. Distinct Uptake Kinetics of Alzheimer Disease Amyloid-β 40 and 42 at the Blood-Brain Barrier Endothelium. Sharda N, Ahlschwede KM, Curran GL, Lowe VJ, Kandimalla KK. J Pharmacol Exp Ther; 2021 Mar 01; 376(3):482-490. PubMed ID: 33303699 [Abstract] [Full Text] [Related]
18. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD). Do TM, Dodacki A, Alata W, Calon F, Nicolic S, Scherrmann JM, Farinotti R, Bourasset F. J Alzheimers Dis; 2016 Mar 01; 49(2):287-300. PubMed ID: 26484906 [Abstract] [Full Text] [Related]
19. 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport. Guo YX, He LY, Zhang M, Wang F, Liu F, Peng WX. Neuroscience; 2016 May 13; 322():28-38. PubMed ID: 26820600 [Abstract] [Full Text] [Related]
20. Selective dihydropyiridine compounds facilitate the clearance of β-amyloid across the blood-brain barrier. Bachmeier C, Beaulieu-Abdelahad D, Mullan M, Paris D. Eur J Pharmacol; 2011 Jun 01; 659(2-3):124-9. PubMed ID: 21497592 [Abstract] [Full Text] [Related] Page: [Next] [New Search]